AMETEK, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AME research report →
Range $255 – $316
Price Chart
About the company
AMETEK, Inc. is a global enterprise that develops and markets a diverse portfolio of electronic instruments and electromechanical devices. The company's operations are structured into two principal divisions: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG).
- CEO
- David A. Zapico
- IPO
- 1984
- Employees
- 22,500
- HQ
- Berwyn, PA, US
Get TickerSpark's AI analysis on AME
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $51.27B
- P/E
- 31.40
- Fwd P/E
- 26.08
- PEG
- 2.63
- P/S
- 6.26
- P/B
- 4.38
- EV/EBITDA
- 23.87
- Div Yield
- 0.59%
- Gross Margin
- 36.64%
- Op Margin
- 26.05%
- Net Margin
- 19.91%
- ROE
- 14.66%
- ROIC
- 8.58%
Latest fiscal year · YoY change
- Revenue
- $7.40B+6.6%
- Gross Profit
- $2.69B+8.7%
- Op Income
- $1.91B
- Net Income
- $1.48B+7.6%
- EPS
- $6.42+7.9%
- OCF Growth
- -1.5%
- FCF Growth
- -1.8%
- Beta
- 0.97
- RSI (14)
- 35
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
AMETEK reported a record quarter with strong organic growth, margin expansion, and raised full-year guidance on the back of broad-based demand and the Indicor acquisition.· November 3, 2026
- Sales hit a record $2.22 billion, up 17% year over year, with organic sales up 10%.
- Orders were $2.65 billion, up 35%, and backlog reached a record $4.54 billion, up 27% from the start of the year.
- Adjusted EPS was a record $2.21, up 17%, above guidance of $2.08 to $2.10.
- Operating margin expanded to 26.8% and core margin to 27.3%, while free cash flow hit a record $527 million.
- Management raised 2026 guidance for sales, EPS, and free cash flow conversion, citing strong Q3 execution and Indicor contributions.
Third-quarter sales were a record $2.22 billion, up 17% year over year; organic sales rose 10% and acquisitions added seven points. Orders were $2.65 billion, up 35%, with organic orders up 17%, and backlog ended at a record $4.54 billion, up 27% from the beginning of the year. Operating income was a record $595 million, up 20%, with operating margin at 26.8% versus 26.2% a year ago; core margin was 27.3%, up 110 basis points. Adjusted diluted EPS was a record $2.21, up 17%, above the $2.08 to $2.10 guidance range. Free cash flow was a record $527 million, up 26%, and operating cash flow was $561 million, up 27%. For 2026, AMETEK now expects sales to be up mid-teens, organic sales up high single digits, adjusted EPS of $8.53 to $8.57 (up 15%), and free cash flow conversion of 115% to 120% of net income. For Q4, management guided to sales up in the low 20% range and adjusted EPS of $2.26 to $2.30, up 12% to 14%.
Dave Zapico said AMETEK is seeing strong momentum across its portfolio, with broad-based organic order growth, secular tailwinds in areas like AI-related infrastructure, defense, energy security, med tech, aerospace, and precision automation. He emphasized the company’s niche-market positioning, pricing power, and ability to offset inflation, and said the Indicor acquisition is fitting well into the AMETEK Growth Model. His tone was upbeat and confident throughout, with repeated references to record performance, strong backlog, and an active M&A pipeline.
Dalip Puri highlighted the quarter’s financial quality, including G&A at 1.4% of sales versus 1.5% a year ago, interest expense of $40 million due to Indicor-related borrowings, and an effective tax rate of 18.5% versus 17.2% last year. He said capital expenditures were $33 million in the quarter and remain expected at about $160 million for 2026, or 2% of sales. He also noted depreciation and amortization of $116 million in the quarter and expects about $470 million for the full year, including roughly $240 million of after-tax acquisition-related intangible amortization. Cash generation remained strong, with operating cash flow of $561 million, free cash flow of $527 million, and gross and net debt-to-EBITDA ratios of 2.3x and 2.1x, respectively, while AMETEK still has $2.7 billion in cash and available credit facilities.
Analysts focused on order cadence, Indicor, backlog conversion, and end-market trends. Management said September was the strongest month for orders and that October started “extremely solid,” while also noting that roughly 80% of backlog is typically shippable in the next 12 months. On Indicor, management said the business contributed a little over $100 million in revenue in the quarter, that $0.08 of EPS contribution is included in full-year guidance, and that year-one synergy targets are 10% to 12% over three years, tracked ratably. They also said the M&A pipeline remains active with “no pause,” and that pricing exceeded about 3% inflation in the quarter.
The quarter showed broad-based demand strength, with organic orders up 17% and record backlog providing visibility into next year. Management is also seeing margin leverage, pricing above inflation, and strong cash generation, while the newly closed Indicor deal appears to be contributing and integrating smoothly.
Some regions and markets are still mixed: Europe was described as the weakest geography, and power remains conservative, growing only mid-single digits despite stronger orders. The company also took on materially more debt after Indicor, with total debt rising to $6.7 billion, so execution on integration and synergy realization matters.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.6%
- Shares Outstanding
- 229.32M
- Float Shares
- 228.37M
of shares held by institutions
1,226 13F filers
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for AME, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Ro KhannaHouse · CA17 | Buy | Sep 4, 26 | Filing → |
| Alan ArmstrongSenate | Buy | Mar 27, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | May 1, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Feb 10, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Jan 9, 26 | Filing → |
| Daniel Milton NewhouseHouse · WA04 | Buy | Aug 18, 25 | Filing → |
| Val HoyleHouse · OR04 | Sell | Jan 24, 25 | Filing → |
| Val HoyleHouse · OR04 | Buy | Oct 29, 24 | Filing → |
| Robert P. BresnahanHouse · PA08 | Sell | Apr 8, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Oct 14, 24 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Sell | Jan 19, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 10, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 10, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Oct 31, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 27.17M | ▼ 4.45K |
| Blackrock, Inc. | 19.25M | ▼ 283.39K |
| Vanguard Capital Management LLC | 15.01M | ▲ 27.08K |
| State Street Corp | 10.45M | ▲ 106.83K |
| Vanguard Portfolio Management LLC | 9.97M | ▲ 21.88K |
| Price T Rowe Associates Inc | 6.57M | ▼ 166.68K |
| Geode Capital Management, LLC | 6.24M | ▲ 100.95K |
| Norges Bank | 4.30M | ▲ 4.30M |
| Fmr LLC | 4.29M | ▲ 15.41K |
| Morgan Stanley | 3.85M | ▲ 102.17K |
| Jpmorgan Chase & Co | 3.75M | ▼ 620.72K |
| Wellington Management Group Llp | 3.16M | ▲ 168.18K |
Held by 1,725 ETFs
Biggest fund positions in AME by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 11, 26 | Stanage Nick L | buy | 4,000 |
| Aug 7, 26 | Hermance David F. | other | 6,608 |
| Aug 7, 26 | Hermance David F. | sell | 6,608 |
| Aug 7, 26 | Hermance David F. | other | 6,608 |
| May 27, 26 | Oscher Ronald J | other | 39,954 |
| May 27, 26 | Oscher Ronald J | other | 39,954 |
| May 7, 26 | Stanage Nick L | other | 0 |
| May 7, 26 | Stanage Nick L | other | 760 |
| Mar 24, 26 | AMATO THOMAS A | other | 500 |
| Mar 24, 26 | AMATO THOMAS A | sell | 530 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AME coverage
Recent articles, reports, and earnings notes.
Want a deeper read on AME?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
